Urology · Houston, TX
NPI
1134551278
Since 2013
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
6560 Fannin St Ste 2100
Houston, TX, 77030
Phone (713) 441-6455
Groups this clinician bills Medicare through
Medicare paid, 2024
$134K
4,374 services
Medicare patients, 2024
236
Average age 73
Drug cost, 2024
$38K
479 prescriptions
Company payments, 2025
$11K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raj Satkunasivam was code J9030 (bcg live intravesical instillation, 1 mg), 3,103 times for 15 patients. In total Raj Satkunasivam billed 4,374 services in 49 codes, and Medicare paid $134K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9030 Bcg live intravesical instillation, 1 mg | Office | 3,103 | 15 | $2.14 | $6,648 |
| 51720 Chemotherapy Administration | Office | 128 | 24 | $63.93 | $8,184 |
| 99205 Office E&M - New | Office | 83 | 83 | $170.38 | $14K |
| 52000 Cystourethroscopy | Office | 83 | 52 | $174.73 | $15K |
| 99214 Office E&M - Established | Office | 83 | 76 | $102.57 | $8,514 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 64 | 16 | $0.36 | $23.02 |
| 99213 Office E&M - Established | Office | 45 | 43 | $65.59 | $2,952 |
| 99215 Office E&M - Established | Office | 32 | 27 | $131.94 | $4,222 |
| 76872 Ultrasound - Nonspecific | Office | 21 | 21 | $109.32 | $2,296 |
| 55700 Other Organ Systems | Office | 21 | 21 | $193.11 | $4,055 |
| 38571 Other Organ Systems | Facility | 16 | 16 | $268.47 | $4,295 |
| 55866 Prostate Resection | Facility | 16 | 16 | $910.52 | $15K |
| 51990 Other Organ Systems | Facility | 12 | 12 | $301.21 | $3,615 |
| 52240 Cystourethroscopy | Facility | 11 | 11 | $319.48 | $3,514 |
By year: 2022 $194K for 8,018 services; 2023 $148K for 6,184 services; 2024 $134K for 4,374 services.
Medicare prescription drug claims, 2024
In 2024, the drug Raj Satkunasivam prescribed most often to Medicare patients was Tamsulosin Hcl, with 134 prescriptions and refills. In total Raj Satkunasivam wrote 479 Medicare prescriptions that cost $38K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 134 | 354 | 40 | $2,129 |
| Ciprofloxacin Hcl Generic | 62 | 62 | 48 | $254 |
| Tramadol Hcl Generic | 49 | 49 | 45 | $70.45 |
| Finasteride Generic | 30 | 90 | Under 11 | $440 |
| Gemcitabine Hcl Generic | 26 | 44 | 18 | $3,576 |
| Docetaxel Generic | 23 | 41 | 16 | $25K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 16 | 16 | 16 | $204 |
| Sodium Chloride 0.9 % Sodium Chloride | 14 | 14 | Under 11 | $188 |
| Amlodipine Besylate Generic | 12 | 18 | Under 11 | $2.58 |
| Metformin Hcl Er Metformin Hcl | 11 | 11 | Under 11 | $0 |
Brand drugs: 62 claims; generic drugs: 417 claims; opioid claims: 60.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Raj Satkunasivam $11K ($9,253 in general payments such as food, travel and fees and $1,270 for research) from 11 companies. The largest payer was Ferring Pharmaceuticals Inc. with $5,481.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.